The importance of informed consent in patients with wet age-related macular degeneration considering intravitreal anti-vascular endothelial growth factor treatments.

McLaughlin, S; Lockington, D; Mansfield, D

McLaughlin, S; Lockington, D; Mansfield, D.

Affiliation

McLaughlin S; Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow G12 0YN, Scotland, UK. sumona_m@hotmail.com

Scott Med J ; 57(1): 48-9, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22408217

Subject(s)

Antibodies, Monoclonal, Humanized/adverse effects; Informed Consent; Intravitreal Injections/adverse effects; Retinal Perforations/etiology; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Wet Macular Degeneration/complications; Antibodies, Monoclonal, Humanized/administration & dosage; Female; Humans; Male; Patient Education as Topic; Ranibizumab; Retrospective Studies; Visual Acuity/drug effects; Wet Macular Degeneration/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Perforations / Vascular Endothelial Growth Factor A / Wet Macular Degeneration / Intravitreal Injections / Antibodies, Monoclonal, Humanized / Informed Consent Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Scott Med J Year: 2012 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google